Novo Nordisk beats on Wegovy sales, expects slower 2025 growth
Danish drugmaker Novo Nordisk reported fourth quarter and full year 2024 earnings Wednesday, beating Wall Street's ...
Is the promise of more affordable weight loss drugs too good to be true? Compounded semaglutide, explained.
Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.
Zacks.com on MSN11d
Novo Nordisk Before Q4 Earnings: How Should Investors Play the Stock?
Novo Nordisk NVO is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks ...
Hims & Hers faces scrutiny from senators on Super Bowl ad that ‘risks misleading' patients
Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...
Crime20d
Woman sheds over 2 stone with slimming 'pen' after menopause weight struggle
New Year's resolutions often focus on improving fitness and health, particularly after the excesses of the holiday season. However, keeping up the momentum for weight loss and exercise can be ...
The Mirror27d
Woman loses 2.3 stone and drops three dress sizes using weight loss 'pen'
choosing a Wegovy weight loss 'pen' to kick start her fitness regime, reports the Express. Wegovy is a weekly injection that supports weight loss by tackling cravings, balancing blood sugar levels ...